Naz Rahman
Stock Analyst at Maxim Group
(0.65)
# 3,431
Out of 4,667 analysts
35
Total ratings
23.53%
Success rate
-20.78%
Average return
Main Sectors:
Stocks Rated by Naz Rahman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PALI Palisade Bio | Maintains: Buy | $23 → $8 | $2.42 | +230.58% | 7 | Nov 13, 2024 | |
| SLXN Silexion Therapeutics | Initiates: Buy | $1 | $0.33 | +205.90% | 1 | Nov 1, 2024 | |
| PRFX PainReform | Downgrades: Hold | n/a | $1.06 | - | 2 | Oct 24, 2024 | |
| VRPX Virpax Pharmaceuticals | Downgrades: Hold | n/a | $0.65 | - | 4 | Oct 9, 2024 | |
| ASRT Assertio Holdings | Initiates: Buy | $3 | $0.95 | +214.30% | 1 | Jul 26, 2024 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $120 | $52.62 | +128.07% | 4 | Jun 4, 2024 | |
| QNRX Quoin Pharmaceuticals | Maintains: Buy | $15 → $4 | $0.64 | +522.28% | 2 | Mar 15, 2024 | |
| VRTX Vertex Pharmaceuticals | Downgrades: Hold | n/a | $450.00 | - | 1 | Jan 31, 2024 | |
| CING Cingulate | Downgrades: Hold | n/a | $4.76 | - | 3 | Dec 19, 2023 | |
| PTPI Petros Pharmaceuticals | Initiates: Buy | $4 | $0.25 | +1,500.64% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.90 | - | 3 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.48 | +237.84% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $20 | $3.46 | +478.22% | 2 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.37 | - | 1 | May 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $3.35 | +79.10% | 1 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $1.09 | +542.20% | 1 | Jan 7, 2022 |
Palisade Bio
Nov 13, 2024
Maintains: Buy
Price Target: $23 → $8
Current: $2.42
Upside: +230.58%
Silexion Therapeutics
Nov 1, 2024
Initiates: Buy
Price Target: $1
Current: $0.33
Upside: +205.90%
PainReform
Oct 24, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.06
Upside: -
Virpax Pharmaceuticals
Oct 9, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.65
Upside: -
Assertio Holdings
Jul 26, 2024
Initiates: Buy
Price Target: $3
Current: $0.95
Upside: +214.30%
Viking Therapeutics
Jun 4, 2024
Reiterates: Buy
Price Target: $120
Current: $52.62
Upside: +128.07%
Quoin Pharmaceuticals
Mar 15, 2024
Maintains: Buy
Price Target: $15 → $4
Current: $0.64
Upside: +522.28%
Vertex Pharmaceuticals
Jan 31, 2024
Downgrades: Hold
Price Target: n/a
Current: $450.00
Upside: -
Cingulate
Dec 19, 2023
Downgrades: Hold
Price Target: n/a
Current: $4.76
Upside: -
Petros Pharmaceuticals
Dec 8, 2023
Initiates: Buy
Price Target: $4
Current: $0.25
Upside: +1,500.64%
Nov 17, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.90
Upside: -
Aug 9, 2023
Initiates: Buy
Price Target: $5
Current: $1.48
Upside: +237.84%
May 11, 2023
Maintains: Buy
Price Target: $13 → $20
Current: $3.46
Upside: +478.22%
May 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $2.37
Upside: -
Feb 25, 2022
Initiates: Buy
Price Target: $6
Current: $3.35
Upside: +79.10%
Jan 7, 2022
Initiates: Buy
Price Target: $7
Current: $1.09
Upside: +542.20%